SelectQuote, Inc. Form 8-K Summary
Business context and reporting period
SelectQuote, Inc. filed this Current Report on September 23, 2020, under Item 5.02 and Item 7.01. The filing reports a Board of Directors change and related press release disclosure. It does not contain a quarterly or annual financial update.
Key financial metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material changes versus the prior comparable period
- Donald Britton resigned as a Class I director effective September 23, 2020.
- The company stated that Mr. Britton’s resignation was not due to any disagreement concerning operations, policies, or practices.
- The Board appointed Kavita K. Patel as a Class I director. Her term runs through the company’s 2020 annual meeting of stockholders.
- Dr. Patel was also appointed to the Board’s Nominating and Governance Committee.
Guidance, outlook, risks, contingencies, and unusual items
No financial guidance, outlook, material risk update, contingency, or unusual financial item was disclosed.
Dr. Patel will receive compensation on the same basis as other non-management directors, as described in the company’s proxy statement under “Director Compensation.” The filing states that she has no reportable related-party transactions with the company and no family relationships with the company’s directors, executive officers, or nominees.
Dr. Patel has been a Nonresident Fellow at The Brookings Institution since February 2011 and has practiced primary care medicine at Mary’s Center since March 2020. She previously practiced at Johns Hopkins Medicine from August 2011 through August 2019.
Facts investors should verify
- Review the company’s 2020 annual meeting materials for the final Board composition and Dr. Patel’s election or term status.
- Review the proxy statement for the applicable non-management director compensation arrangements.
- Review Exhibit 99.1, the September 23, 2020 press release announcing Dr. Patel’s appointment.
- Consult separate periodic filings for SelectQuote’s financial results, liquidity, debt, guidance, and operating risks, which are not addressed in this 8-K.